| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.9183 | 27 |
| GSM780708 | Untreated after 4 days (C2_1) | 57.3325 | 62 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.4682 | 29 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.8343 | 48 |
| GSM780720 | Untreated after 4 days (C2_2) | 57.9609 | 63 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.0873 | 28 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.6771 | 51 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.5605 | 61 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 55.1701 | 60 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.1351 | 42 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.8329 | 61 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.2466 | 52 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 55.498 | 60 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.5705 | 11 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 51.8706 | 54 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.6141 | 39 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.3223 | 49 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.769 | 56 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.7492 | 40 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.2989 | 52 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.0395 | 37 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.3081 | 46 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.116 | 56 |